Novel Life Science Reagents
| Product Number | Product Name | CAS RN | Molecular Formula | Application |
| CL1082 | SB431542 | 301836-41-9 | C22H16N4O3 | |
| CL1006 | Laduviglusib | 252917-06-9 | C22H18Cl2N8 | |
| CL1123 | Lurbinectedin (PM01183) | 497871-47-3 | C41H44N4O10S | |
| CL1372 | Trabectedin (Ecteinascidin 743) | 114899-77-3 | C39H43N3O11S |
|
| CL1556 | LDN-212854 | 1432597-26-6 | C25H22N6 | |
| CL1247 | Abexinostat (PCI-24781) | 783355-60-2 | C21H23N3O5 | |
| CL1248 | AZD-0364 | 2097416-76-5 | C24H24F2N8O2 |
|
| CL2176 | AICAR (Acadesine) | 2627-69-2 | C9H14N4O5 | |
| CLA1004 | Aflibercept | 862111-32-8 | C4318H6788N1164O1304S32 |
|
| CLA1006 | Adalimumab | 331731-18-1 | C6428H9912N1694O1987S46 | |
| CLA1021 | Atezolizumab | 1380723-44-3 | C6446H9902N1706O1998S42 |
|
| CLA1015 | Eculizumab | 219685-50-4 | ||
| CLA1008 | Bevacizumab | 216974-75-3 | C6638H10160N1720O2108S44 | |
| CLA1009 | Rituximab | 174722-31-7 | C6416H9874N1688O1987S44 |
|
| CL1258 | Org 27569 | 868273-06-7 | C24H28ClN3O |
Products
- Category
- Active Pharmaceutical Ingredients
- Pharmaceutical Intermediates
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies & Fusion Protein
- Bioactive Small Molecules
- Stable Isotope Labelled Compounds
- Cytokines
- Dye Reagents
- Drug Impurities & Metabolites
- Natural Products
- Building Blocks & Specialty Chemicals
